ORAMED PHARMACEUTICALS INC. (ORMP) Operating cash flow 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.1MFY2025 · since FY2016: $4.7M → -$9.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.1M | -8.7% |
| FY2024 | -$8.4M | +18.3% |
| FY2023 | -$10.3M | +63.1% |
| FY2022 | -$27.9M | -31.8% |
| FY2021 | -$21.2M | -70.3% |
| FY2020 | -$12.4M | +3.9% |
| FY2019 | -$12.9M | +11.7% |
| FY2018 | -$14.7M | -151.4% |
| FY2017 | -$5.8M | -225.3% |
| FY2016 | $4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice